Phathom Pharmaceuticals (PHAT) Payables (2018 - 2026)
Phathom Pharmaceuticals (PHAT) reported Payables of $6.4 million for Q1 2026, down 45.21% year-over-year from $11.6 million in Q1 2025, and up 27.73% quarter-over-quarter from $5.0 million in Q4 2025.
Phathom Pharmaceuticals (PHAT) Payables (2018 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 9 years of Payables data on file, last reported at $6.4 million in Q1 2026.
- Payables for Q1 2026 came in at $6.4 million, down 45.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.4 million (down 45.21% YoY), and the FY2025 annual result was $5.0 million, down 52.57% from the prior year.
- Payables grew to $6.4 million in Q1 2026 per PHAT's latest filing, from $5.0 million in the prior quarter.
- Over five years, Payables peaked at $12.6 million in Q4 2023 and troughed at $1.1 million in Q3 2025.
- A 5-year average of $6.8 million and a median of $6.4 million in 2026 frame the typical range for Payables.
- The sharpest annual moves came in 2022 and 2025: Payables soared 94.12% in 2022, then tumbled 84.93% in 2025.
- A 5-year view of Payables shows it stood at $10.0 million in 2022, then rose by 26.05% to $12.6 million in 2023, then declined by 16.62% to $10.5 million in 2024, then tumbled by 52.57% to $5.0 million in 2025, then grew by 27.73% to $6.4 million in 2026.
- Business Quant data shows PHAT's Payables at $6.4 million in Q1 2026, $5.0 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Phathom Pharmaceuticals | 895.99 Mn | 712.23 Mn | 46.31 Mn | 6.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.37 Mn |
| Dec 31, 2025 | 4.98 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 4.01 Mn |
| Mar 31, 2025 | 11.62 Mn |
| Dec 31, 2024 | 10.51 Mn |
| Sep 30, 2024 | 7.13 Mn |
| Jun 30, 2024 | 7.66 Mn |
| Mar 31, 2024 | 8.40 Mn |
| Dec 31, 2023 | 12.60 Mn |
| Sep 30, 2023 | 5.79 Mn |
| Jun 30, 2023 | 4.17 Mn |
| Mar 31, 2023 | 4.81 Mn |
| Dec 31, 2022 | 10.00 Mn |
| Sep 30, 2022 | 7.14 Mn |
| Jun 30, 2022 | 5.76 Mn |
| Mar 31, 2022 | 2.86 Mn |
| Dec 31, 2021 | 5.15 Mn |
| Sep 30, 2021 | 5.58 Mn |
| Jun 30, 2021 | 5.40 Mn |